Cargando…
Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk
Control of lipid levels is one of the most effective strategies for cardiovascular (CV) event prevention. In fact, many clinical trials have clearly demonstrated that low-density lipoprotein cholesterol (LDL-C) lowering, primarily with statins, reduces major CV events and mortality. The evidence fro...
Autores principales: | Agabiti Rosei, Enrico, Salvetti, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014894/ https://www.ncbi.nlm.nih.gov/pubmed/27567901 http://dx.doi.org/10.1007/s40292-016-0155-2 |
Ejemplares similares
-
Reduction of High Cholesterol Levels by a Preferably Fixed-Combination Strategy as the First Step in the Treatment of Hypertensive Patients with Hypercholesterolemia and High/Very High Cardiovascular Risk: A Consensus Document by the Italian Society of Hypertension
por: Grassi, Guido, et al.
Publicado: (2022) -
Personalized medicine—a modern approach for the diagnosis and management of hypertension
por: Savoia, Carmine, et al.
Publicado: (2017) -
Less sodium and more potassium to reduce cardiovascular risk
por: Muiesan, Maria Lorenza, et al.
Publicado: (2023) -
Chronic kidney disease and cardiovascular mortality in patients with atrial fibrillation: European Society of Hypertension project – ESH A Fib
por: Premužić, Vedran, et al.
Publicado: (2021) -
Authors’ response to comment on: Less sodium and more potassium to reduce cardiovascular risk and the PURE study
por: Muiesan, Maria Lorenza, et al.
Publicado: (2023)